{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T01:15:03Z","timestamp":1773450903207,"version":"3.50.1"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2012,2,2]],"date-time":"2012-02-02T00:00:00Z","timestamp":1328140800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s11033-012-1506-2","type":"journal-article","created":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T17:49:40Z","timestamp":1328118580000},"page":"6811-6823","source":"Crossref","is-referenced-by-count":17,"title":["Association between the COMT Val158Met polymorphism and breast cancer risk: a meta-analysis of 30,199 cases and 38,922 controls"],"prefix":"10.1007","volume":"39","author":[{"given":"Xiao-Feng","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wu","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shao-Xia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiao","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang-Hua","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,2,2]]},"reference":[{"key":"1506_CR1","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/bjc.1998.187","volume":"77","author":"EM Berns","year":"1998","unstructured":"Berns EM, van Staveren IL, Look MP, Smid M, Klijn JG, Foekens JA (1998) Mutations in residues of TP53 that directly contact DNA predict poor outcome in human primary breast cancer. Br J Cancer 77:1130\u20131136","journal-title":"Br J Cancer"},{"key":"1506_CR2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/ijc.1440","volume":"94","author":"DM Parkin","year":"2001","unstructured":"Parkin DM, Bray F, Ferlay J, Pisani P (2001) Estimating the world cancer burden: globocan 2000. Int J Cancer 94:153\u2013156","journal-title":"Int J Cancer"},{"key":"1506_CR3","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1136\/bmj.321.7261.624","volume":"321","author":"K McPherson","year":"2000","unstructured":"McPherson K, Steel CM, Dixon JM (2000) ABC of breast diseases. Breast cancer epidemiology, risk factors, and genetics. BMJ 321:624\u2013628","journal-title":"BMJ"},{"key":"1506_CR4","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/1471-2407-6-261","volume":"6","author":"X Sim","year":"2006","unstructured":"Sim X, Ali RA, Wedren S, Goh DL, Tan CS, Reilly M (2006) Ethnic differences in the time trend of female breast cancer incidence: Singapore, 1968\u20132002. BMC Cancer 6:261","journal-title":"BMC Cancer"},{"key":"1506_CR5","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1136\/jmg.39.4.225","volume":"39","author":"MM Jong de","year":"2002","unstructured":"de Jong MM, Nolte IM, te Meerman GJ, van der Graaf WT, Oosterwijk JC (2002) Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility. J Med Genet 39:225\u2013242","journal-title":"J Med Genet"},{"key":"1506_CR6","first-page":"843","volume":"8","author":"AM Dunning","year":"1999","unstructured":"Dunning AM, Healey CS, Pharoah PD, Teare MD, Ponder BA (1999) A systematic review of genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev 8:843\u2013854","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1506_CR7","first-page":"419","volume":"7","author":"HC Guldberg","year":"1975","unstructured":"Guldberg HC, Marsden CA (1975) Catechol-O-methyl transferase: pharmacological aspects and physiological role. Pharmacol Rev 7:419\u2013424","journal-title":"Pharmacol Rev"},{"key":"1506_CR8","first-page":"6716","volume":"61","author":"S Dawling","year":"2001","unstructured":"Dawling S, Roodi N, Mernaugh RL, Wang X, Parl FF (2001) Catechol-O-methyltransferase (COMT)-mediated metabolism of catechol estrogens: comparison of wild-type and variant COMT isoforms. Cancer Res 61:6716\u20136722","journal-title":"Cancer Res"},{"key":"1506_CR9","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/00008571-200210000-00003","volume":"12","author":"JE Goodman","year":"2002","unstructured":"Goodman JE, Jensen LT, He P, Yager JD (2002) Characterization of human soluble high and low activity catechol-O-methyltransferase catalyzed catechol estrogen methylation. Pharmacogenetics 12:517\u2013528","journal-title":"Pharmacogenetics"},{"key":"1506_CR10","first-page":"5493","volume":"57","author":"JA Lavigne","year":"1997","unstructured":"Lavigne JA, Helzlsouer KJ, Huang HY, Strickland PT, Bell DA, Selmin O, Watson MA, Hoffman S, Comstock GW, Yager JD (1997) An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer. Cancer Res 57:5493\u20135497","journal-title":"Cancer Res"},{"key":"1506_CR11","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1093\/carcin\/19.11.1943","volume":"19","author":"RC Millikan","year":"1998","unstructured":"Millikan RC, Pittman GS, Tse CK, Duell E, Newman B, Savitz D, Moorman PG, Boissy RJ, Bell DA (1998) Catechol-O-methyltransferase and breast cancer risk. Carcinogenesis 19:1943\u20131947","journal-title":"Carcinogenesis"},{"key":"1506_CR12","first-page":"2107","volume":"58","author":"PA Thompson","year":"1998","unstructured":"Thompson PA, Shields PG, Freudenheim JL, Stone A, Vena JE, Marshall JR, Graham S, Laughlin R, Nemoto T, Kadlubar FF, Ambrosone CB (1998) Genetic polymorphisms in catechol-O-methyltransferase, menopausal status, and breast cancer risk. Cancer Res 58:2107\u20132110","journal-title":"Cancer Res"},{"key":"1506_CR13","first-page":"4870","volume":"59","author":"CS Huang","year":"1999","unstructured":"Huang CS, Chern HD, Chang KJ, Cheng CW, Hsu SM, Shen CY (1999) Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility. Cancer Res 59:4870\u20134875","journal-title":"Cancer Res"},{"key":"1506_CR14","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1054\/bjoc.2001.2009","volume":"85","author":"M Bergman-Jungestrom","year":"2001","unstructured":"Bergman-Jungestrom M, Wingren S (2001) Catechol-O-methyltransferase (COMT) gene polymorphism and breast cancer risk in young women. Br J Cancer 85:859\u2013862","journal-title":"Br J Cancer"},{"key":"1506_CR15","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1093\/carcin\/22.10.1661","volume":"22","author":"JE Goodman","year":"2001","unstructured":"Goodman JE, Lavigne JA, Wu K, Helzlsouer KJ, Strickland PT, Selhub J, Yager JD (2001) COMT genotype micronutrients in the folate metabolic pathway and breast cancer risk. Carcinogenesis 22:1661\u20131665","journal-title":"Carcinogenesis"},{"key":"1506_CR16","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/PL00012073","volume":"6","author":"N Hamajima","year":"2001","unstructured":"Hamajima N, Matsuo K, Tajima K, Mizutani M, Iwata H, Iwase T, Miura S, Oya H, Obata Y (2001) Limited association between a catechol-O-methyltransferase (COMT) polymorphism and breast cancer risk in Japan. Int J Clin Oncol 6:13\u201318","journal-title":"Int J Clin Oncol"},{"key":"1506_CR17","first-page":"635","volume":"10","author":"K Mitrunen","year":"2001","unstructured":"Mitrunen K, Jourenkova N, Kataja V, Eskelinen M, Kosma VM, Benhamou S, Kang D, Vainio H, Uusitupa M, Hirvonen A (2001) Polymorphic catechol-O-methyltransferase gene and breast cancer risk. Cancer Epidemiol Biomarkers Prev 10:635\u2013640","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1506_CR18","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00008571-200106000-00001","volume":"11","author":"DS Yim","year":"2001","unstructured":"Yim DS, Parkb SK, Yoo KY, Yoon KS, Chung HH, Kang HL, Ahn SH, Noh DY, Choe KJ, Jang IJ, Shin SG, Strickland PT, Hirvonen A, Kang D (2001) Relationship between the Val108\/158Met polymorphism of catechol-O-methyl transferase and breast cancer. Pharmacogenetics 11:279\u2013286","journal-title":"Pharmacogenetics"},{"key":"1506_CR19","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00204-002-0387-x","volume":"76","author":"NA Kocabas","year":"2002","unstructured":"Kocabas NA, Sardas S, Cholerton S, Daly AK, Karakaya AE (2002) Cytochrome P450 CYP1B1 and catechol-O-methyltransferase (COMT) genetic polymorphisms and breast cancer susceptibility in a Turkish population. Arch Toxicol 76:643\u2013649","journal-title":"Arch Toxicol"},{"key":"1506_CR20","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1002\/cncr.11340","volume":"97","author":"DE Comings","year":"2003","unstructured":"Comings DE, Gade-Andavolu R, Cone LA, Muhleman D, Mac-Murray JP (2003) A multigene test for the risk of sporadic breast carcinoma. Cancer 97:2160\u20132170","journal-title":"Cancer"},{"key":"1506_CR21","first-page":"453","volume":"25","author":"W Tan","year":"2003","unstructured":"Tan W, Qi J, Xing DY, Miao XP, Pan KF, Zhang L, Lin DX (2003) Relation between single nucleotide polymorphism in estrogen-metabolizing genes COMT, CYP17 and breast cancer risk among Chinese women. Zhonghua Zhong Liu Za Zhi 25:453\u2013456","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"1506_CR22","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/carcin\/bgg022","volume":"24","author":"S Wedren","year":"2003","unstructured":"Wedren S, Rudqvist TR, Granath F, Weiderpass E, Ingelman-Sundberg M, Persson I, Magnusson C (2003) Catechol-O-methyltransferase gene polymorphism and post-menopausal breast cancer risk. Carcinogenesis 24:681\u2013687","journal-title":"Carcinogenesis"},{"key":"1506_CR23","first-page":"7526","volume":"63","author":"AH Wu","year":"2003","unstructured":"Wu AH, Tseng CC, Van Den Berg D, Yu MC (2003) Tea intake, COMT genotype, and breast cancer in Asian\u2013American women. Cancer Res 63:7526\u20137529","journal-title":"Cancer Res"},{"key":"1506_CR24","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1023\/B:BREA.0000025401.60794.68","volume":"85","author":"H Ahsan","year":"2004","unstructured":"Ahsan H, Chen Y, Whittemore AS, Kibriya MG, Gurvich I, Senie RT, Santella RM (2004) A family-based genetic association study of variants in estrogen-metabolism genes COMT and CYP1B1 and breast cancer risk. Breast Cancer Res Treat 85:121\u2013131","journal-title":"Breast Cancer Res Treat"},{"key":"1506_CR25","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1093\/jnci\/djh167","volume":"96","author":"AM Dunning","year":"2004","unstructured":"Dunning AM, Dowsett M, Healey CS, Tee L, Luben RN, Folkerd E, Novik KL, Kelemen L, Ogata S, Pharoah PD, Easton DF, Day NE, Ponder BA (2004) Polymorphisms associated with circulating sex hormone levels in postmenopausal women. J Natl Cancer Inst 96:936\u2013945","journal-title":"J Natl Cancer Inst"},{"key":"1506_CR26","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.tox.2004.06.026","volume":"204","author":"A Sazci","year":"2004","unstructured":"Sazci A, Ergul E, Utkan NZ, Canturk NZ, Kaya G (2004) Catechol-O-methyltransferase Val 108\/158 Met polymorphism in premenopausal breast cancer patients. Toxicology 204:197\u2013202","journal-title":"Toxicology"},{"key":"1506_CR27","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/ijc.20630","volume":"113","author":"TC Cheng","year":"2005","unstructured":"Cheng TC, Chen ST, Huang CS, Fu YP, Yu JC, Cheng CW, Wu PE, Shen CY (2005) Breast cancer risk associated with genotype polymorphism of the catechol estrogen-metabolizing genes: a multigenic study on cancer susceptibility. Int J Cancer 113:345\u2013353","journal-title":"Int J Cancer"},{"key":"1506_CR28","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1158\/1055-9965.EPI-05-0076","volume":"14","author":"L Le Marchand","year":"2005","unstructured":"Le Marchand L, Donlon T, Kolonel LN, Henderson BE, Wilkens LR (2005) Estrogen metabolism-related genes and breast cancer risk: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev 14:1998\u20132003","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1506_CR29","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.cdp.2005.07.003","volume":"29","author":"WY Lin","year":"2005","unstructured":"Lin WY, Chou YC, Wu MH, Jeng YL, Huang HB, You SL, Chu TY, Chen CJ, Sun CA (2005) Polymorphic catechol-O-methyltransferase gene, duration of estrogen exposure, and breast cancer risk: a nested case\u2013control study in Taiwan. Cancer Detect Prev 29:427\u2013432","journal-title":"Cancer Detect Prev"},{"key":"1506_CR30","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00008469-200506000-00010","volume":"14","author":"SC Lin","year":"2005","unstructured":"Lin SC, Chou YC, Wu MH, Wu CC, Lin WY, Yu CP, Yu JC, You SL, Chen CJ, Sun CA (2005) Genetic variants of myeloperoxidase and catechol-O-methyltransferase and breast cancer risk. Eur J Cancer Prev 14:257\u2013261","journal-title":"Eur J Cancer Prev"},{"key":"1506_CR31","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s10549-005-5347-8","volume":"93","author":"F Modugno","year":"2005","unstructured":"Modugno F, Zmuda JM, Potter D, Cai C, Ziv E, Cummings SR, Stone KL, Morin PA, Greene D, Cauley JA (2005) Estrogen metabolizing polymorphisms and breast cancer risk among older white women. Breast Cancer Res Treat 93:261\u2013270","journal-title":"Breast Cancer Res Treat"},{"key":"1506_CR32","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1158\/1055-9965.EPI-04-0392","volume":"14","author":"W Wen","year":"2005","unstructured":"Wen W, Cai Q, Shu XO, Cheng JR, Parl F, Pierce L, Gao YT, Zheng W (2005) Cytochrome P450 1B1 and catechol-O-methyltransferase genetic polymorphisms and breast cancer risk in Chinese women: results from the shanghai breast cancer study and a meta-analysis. Cancer Epidemiol Biomarkers Prev 14:329\u2013335","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1506_CR33","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.breast.2006.03.008","volume":"15","author":"TW Chang","year":"2006","unstructured":"Chang TW, Wang SM, Guo YL, Tsai PC, Huang CJ, Huang W (2006) Glutathione S-transferase polymorphisms associated with risk of breast cancer in southern Taiwan. Breast J 15:754\u2013761","journal-title":"Breast J"},{"key":"1506_CR34","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/1471-2407-6-173","volume":"6","author":"L Gallicchio","year":"2006","unstructured":"Gallicchio L, Berndt SI, McSorley MA, Newschaffer CJ, Thuita LW, Argani P, Hoffman SC, Helzlsouer KJ (2006) Polymorphisms in estrogen-metabolizing and estrogen receptor genes and the risk of developing breast cancer among a cohort of women with benign breast disease. BMC Cancer 6:173","journal-title":"BMC Cancer"},{"key":"1506_CR35","doi-asserted-by":"crossref","first-page":"9781","DOI":"10.1158\/0008-5472.CAN-06-1294","volume":"66","author":"MM Gaudet","year":"2006","unstructured":"Gaudet MM, Chanock S, Lissowska J, Berndt SI, Peplonska B, Brinton LA, Welch R, Yeager M, Bardin-Mikolajczak A, Garcia-Closas M (2006) Comprehensive assessment of genetic variation of catechol-O-methyltransferase and breast cancer risk. Cancer Res 66:9781\u20139785","journal-title":"Cancer Res"},{"key":"1506_CR36","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10549-006-9205-0","volume":"99","author":"MM Gaudet","year":"2006","unstructured":"Gaudet MM, Bensen JT, Schroeder J, Olshan AF, Terry MB, Eng SM, Teitelbaum SL, Britton JA, Lehman TA, Neugut AI, Ambrosone CB, Santella RM, Gammonn MD (2006) Catechol-O-methyltransferase haplotypes and breast cancer among women on Long Island, New York. Breast Cancer Res Treat 99:235\u2013240","journal-title":"Breast Cancer Res Treat"},{"key":"1506_CR37","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/1471-2407-6-114","volume":"6","author":"VU Onay","year":"2006","unstructured":"Onay VU, Briollais L, Knight JA, Shi E, Wang Y, Wells S, Li H, Rajendram I, Andrulis IL, Ozcelik H (2006) SNP\u2013SNP interactions in breast cancer susceptibility. BMC Cancer 6:114","journal-title":"BMC Cancer"},{"key":"1506_CR38","first-page":"1310","volume":"44","author":"CG Song","year":"2006","unstructured":"Song CG, Hu Z, Yuan WT, Di GH, Shen ZZ, Huang W, Shao ZM (2006) Prevalence of Val108\/158Met polymorphism in COMT gene on non-BRCA1\/2 hereditary breast cancer. Zhonghua Wai Ke Za Zhi 44:1310\u20131313","journal-title":"Zhonghua Wai Ke Za Zhi"},{"key":"1506_CR39","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jcla.20139","volume":"21","author":"E Akisik","year":"2007","unstructured":"Akisik E, Dalay N (2007) Functional polymorphism of thymidylate synthase, but not of the COMT and IL-1B genes, is associated with breast cancer. J Clin Lab Anal 21:97\u2013102","journal-title":"J Clin Lab Anal"},{"key":"1506_CR40","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1002\/cncr.22634","volume":"109","author":"DA Ralph","year":"2007","unstructured":"Ralph DA, Zhao LP, Aston CE, Manjeshwar S, Pugh TW, De-Freese DC, Gramling BA, Shimasaki CD, Jupe ER (2007) Age-specific association of steroid hormone pathway gene polymorphisms with breast cancer risk. Cancer 109:1940\u20131948","journal-title":"Cancer"},{"key":"1506_CR41","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1471-2407-7-30","volume":"7","author":"Y Takata","year":"2007","unstructured":"Takata Y, Maskarinec G, Le Marchand L (2007) Breast density and polymorphisms in genes coding for CYP1A2 and COMT: the multiethnic cohort. BMC Cancer 7:30","journal-title":"BMC Cancer"},{"key":"1506_CR42","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1371\/journal.pgen.0030042","volume":"3","author":"PD Pharoah","year":"2007","unstructured":"Pharoah PD, Tyrer J, Dunning AM et al (2007) Association between common variation in 120 candidate genes and breast cancer risk. PLoS Genet 3:e42","journal-title":"PLoS Genet"},{"key":"1506_CR43","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s10549-008-9962-z","volume":"113","author":"C He","year":"2009","unstructured":"He C, Tamimi RM, Hankinson SE, Hunter DJ, Han J (2009) A prospective study of genetic polymorphism in MPO, antioxidant status, and breast cancer risk. Breast Cancer Res Treat 113:585\u2013594","journal-title":"Breast Cancer Res Treat"},{"key":"1506_CR44","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2407-8-6","volume":"8","author":"UV Onay","year":"2008","unstructured":"Onay UV, Aaltonen K, Briollais L, Knight JA, Pabalan N, Kilpivaara O, Andrulis IL, Blomqvist C, Nevanlinna H, Ozcelik H (2008) Combined effect of CCND1 and COMT polymorphisms and increased breast cancer risk. BMC Cancer 8:6","journal-title":"BMC Cancer"},{"key":"1506_CR45","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10549-009-0390-5","volume":"119","author":"A Jakubowska","year":"2009","unstructured":"Jakubowska A, Gronwald J, Menkiszak J, Gor\u2019ski B, Huzarski T, Byrski T, To\u0142oczko-Grabarek A, Gilbert M, Edler L, Zapatka M, Eils R, Lubin\u2019ski J, Scott RJ, Hamann U (2009) BRCA1-associated breast and ovarian cancer risks in Poland: no association with commonly studied polymorphisms. Breast Cancer Res Treat 119:201\u2013211","journal-title":"Breast Cancer Res Treat"},{"key":"1506_CR46","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s10549-009-0407-0","volume":"119","author":"The MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk","year":"2009","unstructured":"The MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk (2009) Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women. Breast Cancer Res Treat 119:463\u2013474","journal-title":"Breast Cancer Res Treat"},{"key":"1506_CR47","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1158\/1055-9965.EPI-08-0917","volume":"18","author":"KW Reding","year":"2009","unstructured":"Reding KW, Weiss NS, Chen C, Li CI, Carlson CS, Wilkerson HW, Farin FM, Thummel KE, Daling JR, Malone KE (2009) Genetic polymorphisms in the catechol estrogen metabolism pathway and breast cancer risk. Cancer Epidemiol Biomarkers Prev 18:1461\u20131467","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1506_CR48","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/ijc.24434","volume":"125","author":"S Sangrajrang","year":"2009","unstructured":"Sangrajrang S, Sato Y, Sakamoto H, Ohnami S, Laird NM, Khuhaprema T, Brennan P, Boffetta P, Yoshida T (2009) Genetic polymorphisms of estrogen metabolizing enzyme and breast cancer risk in Thai women. Int J Cancer 125:837\u2013843","journal-title":"Int J Cancer"},{"key":"1506_CR49","first-page":"217","volume":"30","author":"NB Peterson","year":"2010","unstructured":"Peterson NB, Trentham-Dietz A, Garcia-Closas M, Newcomb PA, Titus-Ernstoff L, Huang Y, Chanock SJ, Haines JL, Egan KM (2010) Association of COMT haplotypes and breast cancer risk in caucasian women. Association of COMT haplotypes and breast cancer risk in caucasian women. Anticancer Res 30:217\u2013220","journal-title":"Anticancer Res"},{"key":"1506_CR50","doi-asserted-by":"crossref","first-page":"683","DOI":"10.5732\/cjc.009.10700","volume":"29","author":"Q Wang","year":"2010","unstructured":"Wang Q, Wang YP, Li JY, Yuan P, Yang F, Li H (2010) Polymorphic catechol-O-methyltransferase gene, soy isoflavone intake and breast cancer in postmenopausal women: a case\u2013control study. Chin J Cancer 29:683\u2013688","journal-title":"Chin J Cancer"},{"key":"1506_CR51","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/01635580903305300","volume":"62","author":"L Delort","year":"2010","unstructured":"Delort L, Satih S, Kwiatkowski F, Bignon YJ, Bernard-Gallon DJ (2010) Evaluation of breast cancer risk in a multigenic model including low penetrance genes involved in xenobiotic and estrogen metabolisms. Nutr Cancer 62:243\u2013251","journal-title":"Nutr Cancer"},{"key":"1506_CR52","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3109\/07357900902744494","volume":"28","author":"VS Syamala","year":"2010","unstructured":"Syamala VS, Syamala V, Sheeja VR, Kuttan R, Balakrishnan R, Ankathil R (2010) Possible risk modification by polymorphisms of estrogen metabolizing genes in familial breast cancer susceptibility in an Indian population. Cancer Invest 28:304\u2013311","journal-title":"Cancer Invest"},{"key":"1506_CR53","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1524-4741.2010.01025.x","volume":"17","author":"AE Cribb","year":"2011","unstructured":"Cribb AE, Joy Knight M, Guernsey J, Dryer D, Hender K, Shawwa A, Tesch M, Saleh TM (2011) CYP17, catechol-o-methyltransferase, and glutathione transferase M1 genetic polymorphisms, lifestyle factors, and breast cancer risk in women on Prince Edward Island. Breast J 17:24\u201331","journal-title":"Breast J"},{"key":"1506_CR54","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3802\/jgo.2011.22.2.110","volume":"22","author":"JZ Cerne","year":"2011","unstructured":"Cerne JZ, Pohar-Perme M, Novakovic S, Frkovic-Grazio S, Stegel V, Gersak K (2011) Combined effect of CYP1B1, COMT, GSTP1, and MnSOD genotypes and risk of postmenopausal breast cancer. J Gynecol Oncol 22:110\u2013119","journal-title":"J Gynecol Oncol"},{"key":"1506_CR55","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s00432-007-0244-7","volume":"133","author":"Z Hu","year":"2007","unstructured":"Hu Z, Song CG, Lu JS, Luo JM, Shen ZZ, Huang W, Shao ZM (2007) A multigenic study on breast cancer risk associated with genetic polymorphisms of ER Alpha, COMT and CYP19 gene in BRCA1\/BRCA2 negative Shanghai women with early onset breast cancer or affected relatives. J Cancer Res Clin Oncol 133:969\u2013978","journal-title":"J Cancer Res Clin Oncol"},{"key":"1506_CR56","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s10549-010-0759-5","volume":"123","author":"HX Ding","year":"2010","unstructured":"Ding HX, Fu YY, Chen WX, Wang ZW (2010) COMT Val158Met polymorphism and breast cancer risk: evidence from 26 case\u2013control studies. Breast Cancer Res Treat 123:265\u2013270","journal-title":"Breast Cancer Res Treat"},{"key":"1506_CR57","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s10549-009-0650-4","volume":"121","author":"C Mao","year":"2010","unstructured":"Mao C, Wang XW, Qiu LX, Liao RY, Ding H, Chen Q (2010) Lack of association between catechol-O-methyltransferase Val108\/158Met polymorphism and breast cancer risk: a meta-analysis of 25,627 cases and 34,222 controls. Breast Cancer Res Treat 121:719\u2013725","journal-title":"Breast Cancer Res Treat"},{"key":"1506_CR58","first-page":"1182","volume":"350","author":"SG Davey","year":"1997","unstructured":"Davey SG, Egger M (1997) Meta-analyses of randomized controlled trials. Lancet 350:1182","journal-title":"Lancet"},{"key":"1506_CR59","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/ije\/dym159","volume":"37","author":"JP Ioannidis","year":"2008","unstructured":"Ioannidis JP, Boffetta P, Little J et al (2008) Assessment of cumulative evidence on genetic associations: interim guidelines. Int J Epidemiol 37:120\u2013132","journal-title":"Int J Epidemiol"},{"key":"1506_CR60","first-page":"719","volume":"22","author":"N Mantel","year":"1959","unstructured":"Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. Natl Cancer Inst 22:719\u2013778","journal-title":"Natl Cancer Inst"},{"key":"1506_CR61","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177\u2013188","journal-title":"Control Clin Trials"},{"key":"1506_CR62","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","volume":"50","author":"CB Begg","year":"1994","unstructured":"Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088\u20131101","journal-title":"Biometrics"},{"key":"1506_CR63","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Smith DG, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629\u2013634","journal-title":"BMJ"},{"key":"1506_CR64","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/10406639408031190","volume":"6","author":"J Weisz","year":"1994","unstructured":"Weisz J (1994) Biogenesis of catecholestrogens: a mechanism for metabolic activation of estrogens. Polycycl Aromat Compd 6:241\u2013251","journal-title":"Polycycl Aromat Compd"},{"key":"1506_CR65","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00008469-199702000-00002","volume":"6","author":"JG Liehr","year":"1997","unstructured":"Liehr JG (1997) Dual role of oestrogens as hormones and pro-carcinogens: tumour initiation by metabolic activation of oestrogens. Eur J Cancer Prev 6:3\u201310","journal-title":"Eur J Cancer Prev"},{"key":"1506_CR66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/carcin\/19.1.1","volume":"19","author":"BT Zhu","year":"1998","unstructured":"Zhu BT, Conney AH (1998) Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis 19:1\u201327","journal-title":"Carcinogenesis"},{"key":"1506_CR67","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1146\/annurev.pa.36.040196.001223","volume":"36","author":"D Yager","year":"1996","unstructured":"Yager D, Liehr JG (1996) Molecular mechanisms of estrogen carcinogenesis. Annu Rev Pharmacol Toxicol 36:203\u2013232","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"1506_CR68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0169-328X(96)00143-X","volume":"43","author":"NJ Butterworth","year":"1996","unstructured":"Butterworth NJ, Dragunow M (1996) Medial septal cholinergic neurons express c-Jun but do not undergo DNA fragmentation after fornix-fimbria transections. Brain Res Mol Brain Res 43:1\u201312","journal-title":"Brain Res Mol Brain Res"},{"key":"1506_CR69","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00008571-199606000-00007","volume":"6","author":"HM Lachman","year":"1996","unstructured":"Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM (1996) Human catechol-o-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6:25\u2013243","journal-title":"Pharmacogenetics"},{"key":"1506_CR70","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1126\/science.758679","volume":"5","author":"PD Scanlon","year":"1979","unstructured":"Scanlon PD, Raymond FA, Weinshilboum RM (1979) Catechol-O-methyltransferase: thermolabile enzyme in erythrocytes of subjects homozygous for allele for low activity. Science 5:63\u201365","journal-title":"Science"},{"key":"1506_CR71","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00125817-200203000-00002","volume":"4","author":"JN Hirschhorn","year":"2002","unstructured":"Hirschhorn JN, Lohmueller K, Byrne E (2002) A comprehensive review of genetic association studies. Genet Med 4:45\u201361","journal-title":"Genet Med"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-012-1506-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11033-012-1506-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-012-1506-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T03:12:17Z","timestamp":1559358737000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11033-012-1506-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,2]]},"references-count":71,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["1506"],"URL":"https:\/\/doi.org\/10.1007\/s11033-012-1506-2","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,2]]}}}